Operationalizing multimorbidity and autonomy for health services research in aging populations - the OMAHA study by Holzhausen, Martin et al.
STUDY PROTOCOL Open Access
Operationalizing multimorbidity and autonomy
for health services research in aging populations -
the OMAHA study
Martin Holzhausen
1*, Judith Fuchs
2, Markus Busch
2, Andrea Ernert
1, Julia Six-Merker
3, Hildtraud Knopf
2,
Ulfert Hapke
2, Beate Gaertner
1,2, Ina Kurzawe-Seitz
2, Roswitha Dietzel
1, Nadine Schödel
2, Justus Welke
4,
Juliane Wiskott
2, Matthias Wetzstein
2, Peter Martus
1, Christa Scheidt-Nave
2
Abstract
Background: As part of a Berlin-based research consortium on health in old age, the OMAHA (Operationalizing
Multimorbidity and Autonomy for Health Services Research in Aging Populations) study aims to develop a
conceptual framework and a set of standardized instruments and indicators for continuous monitoring of
multimorbidity and associated health care needs in the population 65 years and older.
Methods/Design: OMAHA is a longitudinal epidemiological study including a comprehensive assessment at
baseline and at 12-month follow-up as well as brief intermediate telephone interviews at 6 and 18 months. In
order to evaluate different sampling procedures and modes of data collection, the study is conducted in two
different population-based samples of men and women aged 65 years and older. A geographically defined sample
was recruited from an age and sex stratified random sample from the register of residents in Berlin-Mitte (Berlin
OMAHA study cohort, n = 299) for assessment by face-to-face interview and examination. A larger nationwide
sample (German OMAHA study cohort, n = 730) was recruited for assessment by telephone interview among
participants in previous German Telephone Health Surveys. In both cohorts, we successfully applied a multi-
dimensional set of instruments to assess multimorbidity, functional disability in daily life, autonomy, quality of life
(QoL), health care services utilization, personal and social resources as well as socio-demographic and biographical
context variables. Response rates considerably varied between the Berlin and German OMAHA study cohorts
(22.8% vs. 59.7%), whereas completeness of follow-up at month 12 was comparably high in both cohorts (82.9% vs.
81.2%).
Discussion: The OMAHA study offers a wide spectrum of data concerning health, functioning, social involvement,
psychological well-being, and cognitive capacity in community-dwelling older people in Germany. Results from the
study will add to methodological and content-specific discourses on human resources for maintaining quality of
life and autonomy throughout old age, even in the face of multiple health complaints.
Background
Multimorbidity, e. g. the concurrent existence of multi-
ple health problems in the same person, is a highly pre-
valent phenomenon in old age and of growing public
health impact in aging societies [1-3]. The terms multi-
morbidity and comorbidity have been used interchange-
ably. In fact, comorbidity is the older concept and was
first introduced by Feinstein who demonstrated that
comprehensive assessment of concomitant health pro-
blems among patients with a particular index disease is
crucial to explain differences in therapeutic outcome [4].
Due to methodological challenges and limited epide-
miological data, the prevalence, patterns, determinants,
correlates, and consequences of multimorbidity are not
well researched [5,6]. A first and major challenge lies in
the definition of multi- and comorbidity itself. There is
no consensus yet as to which health conditions should
be considered and how exactly they should be assessed,
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overall measure of burden of illness. Apart from quanti-
tative aspects, the type and patterns of concurrent mor-
bidities will matter with respect to treatment options
and prognosis. A second challenge relates to measuring
the impact of multi- and comorbidity [7,8]. As many of
the health complaints people face in old age are chronic
and progressive, and as multiple concurrent conditions
are known to interact, measures of disease-specific treat-
ment success, such as ‘cure’ or reduction in some surro-
gate measure may not be appropriate. The focus of
geriatric outcome research is hence on functional mea-
sures, such as critical exhaustion of specific body func-
tions (often termed as ‘frailty’), functional disability in
daily life, and social participation on one hand and on
subjective measures, such as quality of life (QoL) and
self-determination (autonomy) on the other [9,10]. How-
ever, there is an ongoing debate within health sciences
on how to define these constructs, and on which instru-
ments should be used to assure standardized assessment
and comparability of study results [11-13]. A third and
not too minor challenge lies in the fact that the relation-
ship between multimorbidity and various outcomes is
likely to be modified by a number of medical as well as
non-medical resources and risk-factors. This concept
has been referred to as patient complexity [14]. Exam-
ples for personal resources relevant to maintain auton-
omy and quality of life despite functional impairment
and reduced health status include health-related knowl-
edge, beliefs, competences, and proactive behaviour [15].
External resources include perceived social support, liv-
ing conditions, and quality of health care [14]. Beyond
that, context variables such as socio-demographic and
cultural background as well as critical life events at per-
sonal or societal level need to be considered [16,17].
Against this background, the Federal Ministry of Educa-
tion and Research (BMBF) launched a long term research
initiative on ‘Health in Old Age’. A total of six research
consortia qualified for an initial three-year funding period
(2008-2010) to provide insight into the epidemiology and
socioeconomic consequences of multimorbidity in older
people in Germany [18]. Among these, the Berlin-based
consortium Autonomy Despite Multimorbidity in Old
Age (AMA) focuses on resources and potentials to main-
tain everyday-functioning and self-determination of older
people with multiple health constraints [19].
The population-based AMA subproject OMAHA
(Operationalizing Multimorbidity and Autonomy for
Health Services Research in Aging Populations) aims to
develop a conceptual framework and a set of standardized
instruments and indicators for continuous monitoring of
multimorbidity and associated health care needs in the
population 65 years and above. Main specific goals are: (1)
to develop an algorithm for the comprehensive assessment
of multi- and comorbidity, (2) to analyze patterns, corre-
lates, determinants, and consequences of multi- and
comorbidity; (3) to evaluate an innovative instrument for
preference-based QoL assessment among elders with mul-
timorbidity; (4) to examine the effectiveness and efficiency
of different recruitment strategies and to characterize diffi-
cult-to-reach subgroups of the population 65 years and
older. We describe here the design, methods, study popu-
lation, and data base of the OMAHA study.
Methods/Design
Study design
T h eO M A H As t u d yi sd e s i g n e da sap o p u l a t i o n - b a s e d
longitudinal epidemiological study of multimorbidity in
the population aged 65 years and older. With regard to
methods applied for continuous nationwide health moni-
toring in Germany [20], the OMAHA project uses two dif-
ferent modes of data collection and sampling frames:
(1) assessment by standardized computer-assisted personal
interview (CAPI) and examination in a geographically
defined population sample of men and women 65 years
and older residing in the inner district of Berlin (Berlin-
Mitte) as of July 15, 2008; (2) assessment by standardized
computer-assisted telephone interview (CATI) in a nation-
wide population sample of men and women aged 65 years
and older who participated in previous German Health
Telephone Surveys and had agreed to be re-contacted. In
each case, the study protocol consisted of a comprehensive
assessment at baseline and at 12-month follow-up. In
addition, short intermediate telephone follow-up inter-
views for assessment of vital and functional status were
conducted at month 6 and 18.
The study was approved by the local ethics committee
at Charité - Universitätsmedizin Berlin and conducted in
compliance with data protection and privacy regulations
as requested by the Federal and Berlin Offices for the
Protection of Data. Study participants were informed in
detail about the study objectives, interview and examina-
tion procedures as well as pseudonymized record keeping
and subsequent data analysis. Persons participating in
the personal interview and examination gave written
informed consent prior to study inclusion. A subset also
provided written permission to contact their family doc-
tor for validation of specific self-reported medical condi-
tions (e. g., ischemic heart disease, diabetes, asthma,
chronic bronchitis). Oral informed consent to study par-
ticipation was obtained from participants in previous
German health telephone surveys before conducting the
OMAHA baseline CATI.
Sampling procedures and recruitment of study
participants
For the Berlin OMAHA cohort, we drew an age (65-69,
70-74, 75-79, 80-84, 85+ years) and sex stratified random
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from the official register of residents in Berlin-Mitte as of
July 15, 2008. All individuals of the population sample
who were then verified as alive, still living in Berlin-Mitte
and available during the study recruitment period were
eligible for the study. Exclusion criteria were: death, per-
manent change of residence outside of Berlin-Mitte or to
an unknown address, and continuous absence from
Berlin during study recruitment period. Anticipating an
overall response rate of about 20% and an overall propor-
tion of unverifiable contacts of 5-10%, the total sample
size was sufficiently large to achieve a study population
of n = 300 for the main study and of n = 100 for preced-
ing pre-test evaluation.
To assure public support of the study, we communi-
cated the study goals and logistics to members of the
Berlin Medical Association via the official journal of
the Berlin Medical Association (Anonymous, 2009) and
to community officials (e. g., local police stations,
churches) via telephone contacts.
Individuals belonging to the main sample were initially
contacted by post. The letters contained a brief descrip-
tion of the study, an invitation to participate, and a pre-
paid self-addressed envelope together with a return
sheet to fill in telephone numbers, preferred contact
times, and choice of home or study centre visit for the
assessment. Participants were offered a small monetary
incentive (€ 10) plus reimbursement for travel expenses.
Foreign nationals were offered a brief description of the
study in seven different languages (Turkish, Russian,
Arabic, Serbian, Croatian, Polish, and English).
In order to identify and further characterize persons
who did not participate, we explicitly asked family mem-
bers or caregivers to respond in case that an eligible
person was not able to participate due to cognitive
impairment or severe illness and to consent to proxy
telephone interviews.
Among persons who did not respond to the initial
mailed invitation, we conducted a randomized con-
trolled trial which evaluated the effectiveness and effi-
ciency of three different intensified recruitment
strategies: (a) personal visits, (b) telephone calls, or (c)
mailed reminder letters including the initial invitation
letter and enclosures. Statistical analysis of this com-
parative evaluation of recruitment strategies is com-
pleted and results are currently prepared for publication
in a separate paper.
The German OMAHA cohort was recruited from a pool
of persons who had previously participated in the
German Telephone Health Surveys 2004 or 2006.
Nationwide telephone health surveys have been con-
ducted in Germany annually by the Robert Koch Institute
since 2002/2003; sampling procedures and recruitment
strategies have been previously described in detail [21].
In brief, telephone numbers from complete listings of
landline telephone connections belonging to private
households in Germany are randomly generated, apply-
ing the Gabler-Häder method [22]. This method assures
that households with unregistered telephone numbers
are included in the ‘target sample’ of telephone surveys.
Random sampling at the individual level is achieved by
the ‘next-birthday-method’, i.e. only the adult whose
birthday is coming up next to the date of first contact to
the respective household is included in the target sample.
Automated redialling systems and computer-assisted
interviewer guidance assure that telephone contact and
interview procedures are conducted in a highly standar-
dized and efficient way. In the 2004 and 2006 German
Telephone Health Surveys, 56.1% and 56.6% of contacted
persons 18 years of age and older completed the survey
(3376 men; 3965 women in 2004 [23]; 2682 women and
2860 men in 2006 [24]). The majority of survey partici-
pants 65 years and older (n = 1263 or 87.4% in 2004,
and n = 846 or 86.0% in 2006) consented to be re-
contacted by the Robert Koch Institute for future health
surveys. Excluding n = 557 persons who were part of a
random sample included in a European telephone health
survey, a total of n = 1552 men and women remained to
be re-contacted for the OMAHA baseline telephone
assessment.
Response and analysis of non-response bias
Of the total Berlin sample, 519 persons (26.0%) had
initially been contacted for preceding pre-test evalua-
tion, leaving a total of n = 1481 persons for the main
study (Figure 1). Of these, 173 persons (11.7%) were
excluded as they had died (n = 68), had changed resi-
dence (n = 85), or were absent during the entire recruit-
ment period (n = 20). Of the 1308 eligible persons, 299
(22.9%) participated in the study and completed the full
baseline assessment between January and June 2009.
Among 1009 non-participants, n = 384 (38.1% of non-
participants) declined full assessment but completed a
short questionnaire (also available in the seven different
languages mentioned above) covering self-rated health,
limiting longstanding illness, disability, care dependency,
living arrangements and marital status; n = 324 (32.1%
of non-participants) declined both full assessment and
short questionnaire; and n = 301 (29.8%) did not
respond to all our contacts. The short questionnaires
were administered via standardized telephone interview
or self-administered postal questionnaires which were
returned in a self-addressed prepaid envelope. Among
n = 296 participants surviving to the 6-month-follow-
up, n = 291 (98.3%) completed the brief 6-month fol-
low-up questionnaire delivered by standardized tele-
phone interview. The 12-month follow-up assessment
was conducted between January and April 2010 and is
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ing to 12 months). The concluding 18-month telephone
follow-up was completed in October 2010 for n = 262
participants (91.0% of 288 participants surviving to
month 18).
For preceding pre-test evaluation, a random sample of
n = 100 stratified by sex and five age groups (65-69, 70-
74, 75-79, 80-84, 85+ years) was drawn from the Ger-
man Telephone Health Survey sample 2007 [25].
N = 1552 participants in previous German Telephone
Health Surveys 2004 and 2006 were selected for the
OMAHA study (Figure 2), 329 persons (21.2%) were
excluded because they had died or their telephone num-
bers were found to be disconnected. Of the remaining
1223 persons, 730 (59.7%) completed the OMAHA
baseline assessment via computer-assisted telephone
interview (CATI) between March and April 2009.
Among non-participants, the majority (n = 334) refused
to participate, while some persons (n = 23) started but
did not complete the telephone interview, and n = 135
(27.5%) could not be reached during the baseline study
period. Of baseline participants, n = 670 (91.8%) com-
pleted the brief 6-month telephone follow-up, adminis-
tered via CATI. Among the 60 persons not continuing
into follow-up, 5 had died in the interim, 30 refused to
participate (11 stating that decision directly after base-
line assessment), and 25 could no longer be reached by
the given telephone number. The full 12-month follow-
up assessment was conducted in May and June 2010
and was completed for n = 593 (81.2%) of OMAHA
baseline study participants (Figure 2). The concluding
18-month telephone follow-up is currently underway
and will be completed by January 2011.
Non-response analyses will be conducted based on
comparisons of key health and socio-demographic char-
acteristics between participants and non-participants.
For the nationwide cohort such information can be
extracted from data collected during previous German
Figure 1 Response in the Berlin OMAHA cohort.
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cohort, information on age, sex, nationality, nursing
home residence, and area deprivation score was available
from the dataset provided by the residents registration
office in Berlin-Mitte and official social statistics for the
city of Berlin. Further comparisons between participants
and non-participants with respect to health and disabil-
ity as well as social networks and care dependence will
be limited to the 38% subset of non-participants who
answered a brief questionnaire for baseline assessment.
Constructs and instruments
Within the conceptual framework depicted in Figure 3,
we selected and composed a set of instruments that
would permit to provide valid, reliable, and efficient mea-
sures of (a) multimorbidity, (b) potential consequences of
multimorbidity, including impairment of body functions
and frailty, autonomy, quality of life,a n dhealth care ser-
vices utilization, (c) personal and social resources likely to
modify the association between multimorbidity and
outcome measures, (d) socio-demographic and biogra-
phical context variables.
Selection of instruments was based on extensive litera-
ture review and feasibility pre-testing. Table 1 provides
an overview of the main theoretical constructs, con-
struct domains, and instruments. Assessment tools were
aligned as closely as possible between the two OMAHA
study arms (Berlin cohort and German cohort). Never-
theless, constructs covered and instruments used for
their measurement differed to some degree according to
the different assessment modes.
The theoretical construct of multimorbidity is com-
posed of two domains: (a) health status as assessed by
self-reported physician-diagnosed health conditions,
history of surgical procedures, history of fractures past
age 50 years, medication use within 7 days prior to the
interview, and standardized measures (Berlin cohort
only) of height, weight, waist and calf circumference,
and blood pressure; (b) self-reported current symptoms
and complaints including sensory limitations (vision
Figure 2 Response in the German OMAHA cohort.
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nence, constipation, back pain, and joint complaints.
Overall, 31 specific health conditions were covered in
the CAPI and CATI following a standardized sequence
of questions on first and last time of occurrence of
symptoms, medical treatment within the past 12
months, and perceived level of condition specific lim-
itation in daily life (Figure 4). Current symptoms of
depression as assessed by the Patient Health Question-
naire (PHQ) were used as an indicator of mental
health. Operations, falls (only Berlin cohort), and
health services utilization were also assessed. Func-
tional assessment covered (a) a short neuropsychologi-
cal test battery, (including tests of orientation, episodic
memory, verbal fluency, and psychomotor speed) and
(b) standardized measures of physical functioning
(including measures of grip strength, balance, and
lower extremity dysfunction. The digit symbol substi-
tution test (DSST) and physical functioning tests were
restricted to the Berlin OMAHA study cohort. Con-
ceptualizing frailty as a critical exhaustion of specific
body functions or combinations of body functions we
used previously published cut-off levels [26-29]. In this
context, self-reported weight loss within the past 12
months, height loss since age 25 years, and history of
falls within the past 12 months and the past four
weeks were also assessed.
Standardized anthropometric measurements and auto-
mated assessment of current medication use were limited
t ot h eB e r l i nO M A H As t u d yc o h o r t .Ac o m p l e t ei n v e n -
tory of all medications used within 7 days prior to the
interview (including prescriptions as well as non-pre-
scription drugs) was assured by scanning the original
containers brought to the examination site for that
purpose. All drugs were automatically coded by an
underlying software system to the WHO-ATC system.
Details on medication use also included self-reported
indications, form of administration, frequency of intake,
origin of the medicine, and duration of use.
Autonomy is conceptualized twofold as (a) absence of
disability in daily life and dependence on care, and (b)
perceived self-determination. Disability and dependence
on care were assessed by standardized CAPI or CATI,
covering questions on limitations in activities of daily
living (ADL, IADL), and everyday competence. Ques-
tions on subjective self-determination were covered in
the self-administered questionnaire and are hence lim-
ited to the Berlin cohort.
Quality of life comprises the following domains: self-
rated health, subjective well-being and vitality, pain,
health-related QoL, global life satisfaction, and prefer-
ence-based quality of life. All of these except prefer-
ence-based quality of life were assessed in both
OMAHA cohorts by validated instruments via standar-
dized interview (CAPI or CATI) or self-administered
questionnaire. Preference-based QoL was assessed only
in the Berlin cohort by the newly developed tool FLQM
(’Fragebogen zur Lebensqualität multimorbider älterer
Menschen’) as part of the CAPI. Additional instruments
to measure global life satisfaction (Satisfaction with Life
Scale, SWLS) and subjective well-being (International
Positive and Negative Affect Schedule, IPANAS) were
administered in the Berlin cohort only.
Resources can roughly be divided into personal, social
and organizational resources. As facets of personal
resources, individual health-related behaviours (alcohol
consumption, nutrition, tobacco use, physical activity),
educational status, and income as well as housing and
environment were assessed in both OMAHA cohorts by
standardized self-administered questionnaire or CATI.
Proactive coping as another important personal resource
was assessed by the Proactive Coping Inventory (PCI) via
self-administered questionnaire in the Berlin cohort only,
since the PCI is not suitable for administration via CATI.
As part of the social resource domain, social contacts
were assessed in both OMAHA cohorts by the same vali-
dated instrument (MILVA). In lack of a validated instru-
ment for administration by CATI, the assessment of
subjective social support (by BSSS) was restricted to the
Berlin OMAHA cohort. Organizational resources
assessed were health insurance, family doctor, housing
and environment, and nursing care level within the Ger-
man healthcare system. Additional context variables cov-
ered age, critical life events, and migration background.
Power analysis
Due to the exploratory nature of the study and the multi-
plicity of outcomes, no power calculation was considered.
Biographical and societal context
Multimorbidity/comorbidity
Functional impairment
Extrapersonal
resources
Personal
resources
Disability
Social participation
Autonomy
Quality of life
Health-care services utilization
Mortality
Figure 3 Framework of the OMAHA Study.
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Theoretical Construct and Facets Measure Berlin
cohort
German
cohort
Multimorbidity
Long-standing or chronic disease Minimum European Health Module (MEHM)[31,32] PI TI
Diseases and health problems Closed-ended questions on medical conditions and health problems (cf. Figure
2)
a
PI TI
Operations Open-ended questions for surgery since age 40, followed by closed-ended
questions
a
PI TI
Regular medication Closed-ended question
a PI TI
Depression Patient Health Questionnaire (PHQ2/9)[33,34] PI TI
Medication Barcode scanning and assessment of currently used medication[20] PI -
Falls Closed-ended questions according to[35] PI TI
Fractures List
a PI -
Medical care According to German National Health Interview and Examination Survey[30] SQ TI
Blood pressure Blood pressure meter
b PI -
Weight Electronic scales
c PI -
Height Portable stadiometer
d PI -
Circumference of waist, calf, arm Flexible measuring tape
e PI -
Quality of Life
Self-rated overall health Minimum European Health Module (MEHM; also question 2 in SF-36)[31,32] PI TI
Global life-satisfaction Single question
a PI TI
Global life-satisfaction Satisfaction With Life Scale (SWLS)[36] PI -
Global life-satisfaction Fragebogen zur Lebensqualität multimorbider älterer Menschen (FLQM)[37] PI -
Subjective well-being International Positive and Negative Affect Schedule (IPANAS)[38,39] PI -
Comparative self-rated overall health Closed-ended questions
a SQ -
Health-related quality of life EQ-5D[40,41] SQ TI
Subjective well-being Vitality sub-scale of SF-36[42,43] SQ TI
Pain Questions 7 and 8 of SF-36; adapted time-frame[42,43] SQ TI
Autonomy
Limitations due to health problem Minimum European Health Module (MEHM)[31,32] PI TI
Need for assistance Closed-ended questions modified from[44] PI TI
Functional health I: ADL According to Katz[45,46] PI TI
Functional health I: IADL According to Lawton & Brody[47,48] PI TI
Functional health II: Functional
limitations
Closed-ended questions adapted from[32] SQ TI
Autonomy Wahrgenommene Autonomie im Alter (WAA)[49] SQ -
Resources (incl. Socio-Demography) and Performance Tests
Year of birth According to German National Health Interview and Examination Survey[30] PI TI
Gender According to German National Health Interview and Examination Survey[30] PI TI
Marital status According to German National Health Interview and Examination Survey[30] PI TI
Education and employment According to German National Health Interview and Examination Survey[30] PI TI
Net household income According to German National Health Interview and Examination Survey[30] PI TI
Household size Closed-ended questions [24] PI TI
Number of and contact with
children
Closed-ended questions[44] PI TI
Religion Closed-ended question [50] PI TI
Migration According to Schenk et al.[51] PI TI
Health insurance According to German National Health Interview and Examination Survey[30] SQ -
Nursing care level Closed-ended question
a PI TI
Housing and environment Mannheimer Inventar der Lebensverhältnisse im Alter (MILVA), subscale,
housing’[52]
SQ TI
Social contacts Mannheimer Inventar der Lebensverhältnisse im Alter (MILVA), subscale,
contacts’[52]
SQ TI
Social support Berliner Social Support Scales (BSSS)[53] SQ -
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A statistician supervised, validated, and where necessary
corrected the data throughout the process of data-col-
lection. Cleaned final data sets were provided by the sta-
tistician within less than 6 months after the completion
of data collection. A detailed documentation of the pro-
cess was continuously accessible to the research team.
Quality assurance
To achieve a high degree of standardization in the sur-
vey, the study nurses for personal interviews (CAPI)
were initially trained and continuously supervised. Addi-
tional training sessions took place before the 12-months
follow-up. Telephone interviewers were highly experi-
enced in carrying out telephone health surveys and
received specific training before the baseline interview
as well as before the 6-month and 12-month follow-up
interviews. Standard operation procedures (SOPs) were
supplied for all parts of the computer-assisted interviews
(CAPI and CATI), functional assessments, and anthro-
pometric measurements. Quality standards and require-
ments for internal quality control were developed
according to recognized epidemiological guidelines and
standards applied in German Health Interview and
Examination Surveys [30].
Discussion
The OMAHA project is a longitudinal epidemiological
study in two population-based cohorts of older people
aged 65 years or older using different methods of data
collection. In the urban cohort (Berlin cohort), an age-
and sex-stratified sample of residents of an inner-city
district of Berlin was assessed by face-to-face interviews,
self-administered questionnaires and measurement of
physical functions and body measures. In the nationwide
cohort (German cohort), participants of former German
Health Telephone Surveys were assessed by telephone
interview.
Our research is focused on the development of a com-
prehensive assessment of multi- and comorbidity and the
analysis of patterns, correlates, determinants, and conse-
quences of these. Also, an innovative instrument for pre-
ference-based QoL assessment among elders suffering
from multimorbidity will be evaluated. On the methodo-
logical level, we examine the effectiveness and efficiency
of different recruitment strategies and will characterize
difficult-to-reach subgroups of the population 65 years
and older. Data collection comprises four waves in each
of the two cohorts: two more extensive waves at baseline
and 12-month follow-up, and two very brief waves at
months 6 and 18 from baseline assessment. This opens
Table 1 Constructs, facets, and measurement tools in OMAHA (Continued)
Nutrition Mini Nutritional Assessment (MNA)[54] PI TI
Changes in height and weight Open-ended questions
a PI TI
Healthcare products List
a PI TI
Alcohol consumption Alcohol Use Disorders Identification Test - alcohol consumption questions
(AUDIT-C)[55,56]
SQ TI
Smoking According to German National Health Interview and Examination Survey[30] SQ TI
Medication addiction Severity of Dependence Scale (SDS)[57,58] SQ -
Physical activity Closed-ended questions
a SQ TI
Activities List
a SQ -
Critical life-events List following[59] SQ -
Coping Proactive Coping Inventory PCI[15] SQ -
Cognitive function: Episodic memory Memory Impairment Screen (MIS)[26,60,61] PI TI
Cognitive function: Verbal fluency Verbal fluency subtest of the CERAD test battery[62,63] PI TI
Cognitive function: psychomotor
speed
Digit symbol substitution test of WAIS (adapted German version from BASE)
[64,65]
PI -
Cognitive function: Temporal
orientation
Subscale orientation of the ADAScog[26,66] PI TI
Grip Strength Smedley dynamometer[67,68] PI -
Functional Mobility Timed Up and Go-Test[27] PI -
Lower extremity function Chair-Rise-Test[28] PI -
Balance According to Guralnik[29] PI -
PI = personal interview/assessment; SQ = self-complete questionnaire; TI = telephone interview.
a Self-developed questionnaire.
b Datascope Accutor Plus, the Netherlands.
c SECA, Germany, accuracy of measurement 0.1 kg.
d Holtain Ltd., UK, accuracy of measurement 0.1 cm.
e Hoechstmass, Sulzbach, Germany, accuracy of measurement 0.1 cm.
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tories of health states, longitudinal relationships of out-
come determinants, and, most importantly, causal
relationships between conditions and trajectories over a
period of 18 months.
The parallel application of instruments in the two
cohorts and modes of administration (CAPI and CATI)
will on the one hand allow us to identify those tools
that are most suitable for telephone administration. On
the other hand, we will also be able to make compari-
sons between the urban Berlin cohort and the nation-
wide cohort with respect to selected variables cross-
sectionally as well as longitudinally. The wide variety of
measures relating to similar constructs allows us to
soundly determine the psychometric properties of adap-
tations and new developments for geriatric and geronto-
logical assessments in older age groups. After the
completion of analyses relating to validity and reliability
of (1) adaptations of existing measurement tools and (2)
the newly developed quality of life assessment tool
(FLQM) we will be able to provide a wide-ranged set of
instruments and tools for personal and telephone assess-
ment in population-based health surveys.
Clearly, the samples are subject to selective inclusion.
Within the Berlin cohort, there were considerable differ-
ences in sample structure with respect to different
major sub-populations, such as migrants or people living
in nursing-homes and socio-economically deprived
areas. In addition to the specified sub-populations, peo-
ple suffering from dementia or cognitive impairment
and those who are heavily restricted in their sensory
capacity are not likely to be adequately represented in
both cohorts. Because determining barriers and evaluat-
ing recruitment strategies are among our goals, we did
not expect the participating sample to be representative.
In contrast, analyses of the effectiveness and efficiency
of the three different recruitment strategies in the Berlin
cohort and detailed analysis of participant/non-partici-
pant characteristics in both cohorts will enable us to
derive strategies on how to get better access to, and
response from, these groups. In future studies, a strategy
of oversampling underrepresented, yet notably prevalent
and politically important groups could serve as one
means to minimize selection bias.
OMAHA offers a wide spectrum of data related to
health, functioning, social involvement, psychological
well-being, and cognitive capacity throughout old age in
Germany, opening up new opportunities for further ger-
ontological and geriatric research. Results from the study
will add to methodological as well as content-specific dis-
courses on human resources for maintaining high levels
of autonomy and quality of life in old age, even in the
face of multiple health burdens and morbidity.
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Nt no
yes
Next
disease Did you ever suffer from XXX?
no
yes Was XXX diagnosed by a physician/GP?
at the age of ___
in the year ___
4k
When did XXX first occur?
past 4 weeks
less than 12 months
before that
When did XXX last occur?
no, not at all
no
yes
Did you take any medication within the 
past 12 months because of XXX or were 
you professionally treated?
a little
moderately
strongly
very strongly
Are you limited in your everyday 
abilities because of XXX at the moment?
Figure 4 Assessment of morbidity in OMAHA.
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